The Thalassaemia International Federation (TIF) works in official relations with the World Health Organization (W.H.O.), since 1996 and more specifically with the Chronic Diseases and Health Promotion Department (CHP).
TIF has focused much attention and has been working for many years with the Human Genetics Program office, which falls within the department the Chronic Disease Prevention and Management of the Non-Communicable Disease section. Currently, this department is being coordinated by Dr Shanthi Mendis.
- Co- organizes or co-sponsors educational programmes at the regional and/or international level with WHO Regional Offices or the WHO headquarters.
- Attends and contributes to the Executive Board Meetings and/or the World Health Assemblies, through 3-minute statement interventions.
- Works with the Regional Offices of the W.H.O., organizing and performing various activities in each Region including the preparation of Guidelines for the management of haemoglobin disorders particularly tailored to address the problems specific to a region.
TIF has also a great interest and contributes in various other areas of work of the W.H.O. such as:
Blood Safety and Quality of Transfusions
TIF has contributed greatly in the adoption, in May 2006, of the following two resolutions, which pertain specifically to haemoglobinopathies: EB118.R1 on thalassaemia and other haemoglobinopathies and WHA59.20 on sickle cell anaemia.
Read TIF’s Statement to the Consultation for the Inclusion of Whole Blood & Red Blood Cells of the WHO Essential Medicines List.